BRCA2 has an essential function in DNA repair by homologous recombination, interacting with RAD51 via short motifs in the middle and at the C terminus of BRCA2. Here, we report that a conserved 36-residue sequence of human BRCA2 encoded by exon 27 (BRCA2 Exon27 ) interacts with RAD51 through the specific recognition of oligomerized RAD51 ATPase domains. BRCA2 Exon27 binding stabilizes the RAD51 nucleoprotein filament against disassembly by BRC repeat 4. The protection is specific for RAD51 filaments formed on single-stranded DNA and is lost when BRCA2 Exon27 is phosphorylated on Ser3291. We propose that productive recombination results from the functional balance between the different RAD51-binding modes of the BRC repeat and exon 27 regions of BRCA2. Our results further suggest a mechanism in which CDK phosphorylation of BRCA2 Exon27 at the G 2 -M transition alters the balance in favor of RAD51 filament disassembly, thus terminating recombination.
The inheritance of a mutated copy of the BRCA2 gene confers a high lifetime risk of developing breast, ovarian and other cancers 1, 2 . This risk is explained by the fundamental role of the BRCA2 tumor suppressor in preserving the integrity of DNA. BRCA2-deficient cells are defective in DNA repair 3, 4 and show an accumulation of chromosomal breaks 5, 6 . BRCA2 carries out an essential role in the repair of double-stranded DNA (dsDNA) breaks by homologous recombination, via its ability to regulate the RecA-related recombinase RAD51 (refs. 6-9) . BRCA2 targets RAD51 to the site of damaged DNA and promotes formation of the RAD51-single-stranded DNA (ssDNA) nucleoprotein filament, the molecular species that performs the reactions of homology search and strand exchange underlying homologous recombination [10] [11] [12] [13] . However, the precise mechanism by which BRCA2 directs RAD51-mediated homologous recombination upon DNA damage remains to be elucidated 14 .
The remarkable size of the human BRCA2 protein (3,418 amino acids) has so far precluded investigation of its recombination function in vitro. Studies have instead concentrated on the regions of BRCA2 that are known to function in homologous recombination (Fig. 1a) . Exon 11 of the BRCA2 gene codes for a large central region of the protein that houses eight B35-residue BRC repeats, six of which are known to bind RAD51 (refs. 15-17) . Another RAD51-binding motif is present in the extreme C terminus of BRCA2, encoded by exon 27. The exon 27 region is highly conserved in vertebrate BRCA2 proteins and is unrelated in sequence to the BRC repeats 7, 18 . A large conserved C-terminal portion of BRCA2 can bind single-stranded DNA 10 ; recent evidence indicates that this C-terminal domain localizes the BRCA2-RAD51 complex to ds-ssDNA junctions that are created at double-strand break loci, thus initiating formation of nucleoprotein filaments 12 .
The rationalization of BRCA2's activity in DNA repair requires a detailed functional understanding of RAD51 binding by the BRC repeat and exon 27 regions. Proteins of the RecA/RAD51/RadA family of recombinases assemble spontaneously in homo-oligomeric forms consisting of rings or filaments [19] [20] [21] [22] [23] [24] [25] (Fig. 1b) . Individual BRC repeats can disrupt RAD51 oligomers and RAD51 nucleoprotein filaments through the formation of a 1:1 complex between monomeric RAD51 and the BRC repeat 8, 16, 26 (Fig. 1c) . Notably, BRC repeats interrupt RAD51 oligomerization by a mechanism that mimics the mode of RAD51 self-association 26 . Potential roles for the disruptive function of BRC repeats include sequestration and transport of RAD51 to the site of DNA damage, remodeling of RAD51 oligomers into nucleoprotein filaments and disassembly of established nucleoprotein filaments 11, 12 . Biochemical evidence has emerged for a further role of the BRC repeats in recombination: under certain conditions, BRC repeats can associate with RAD51 nucleoprotein filaments 27 , and a large BRCA2 segment spanning all eight BRC repeats (BRCA2 BRC1-8 ) can stimulate RAD51-mediated strand exchange in vitro 11 . Together, these observations provide a multifaceted picture of BRC repeats' involvement in the process of recombinational repair. The abilities of individual BRC repeats and the BRCA2 BRC1-8 region to interact with RAD51 in ways that can interfere or be compatible with filament assembly (O.R.D. and L.P., unpublished data, and refs. 11, 16, 27) suggest that the different binding modes must be strictly controlled in cells during the different stages of the repair process. How the appropriate balance between the multiple functions of BRC repeats is achieved during recombination-mediated repair remains unknown.
The presence of a RAD51-binding site within the C-terminal exon 27 region of BRCA2 was originally discovered by yeast two-hybrid analysis and later confirmed biochemically 7, 18, 28 (Fig. 1d) . Exon © 2007 Nature Publishing Group http://www.nature.com/nsmb 27 deletion induces increased tumor incidence and reduced lifespan in mice 29, 30 and hypersensitivity to DNA cross-linking agents and lack of RAD51 foci formation in cells 31 . These studies indicate that the exon 27 region is functionally relevant to the essential role of BRCA2 in preserving the integrity of the genome. Recent evidence shows that Ser3291, encoded within exon 27, undergoes CDK-dependent phosphorylation at the G 2 -M phase transition and dephosphorylation upon DNA damage 28 . The finding that Ser3291 phosphorylation abrogates RAD51 binding as cells progress into mitosis suggests that the BRCA2 exon 27-RAD51 interaction is relevant to homologous recombination and that its disruption contributes toward the termination of recombination 28 . However, the lack of information regarding the mode of RAD51 binding by the exon 27 region of BRCA2 currently restricts our understanding of its function.
Here we report an experimental investigation of the interaction between a highly conserved exon 27 sequence of human BRCA2 (amino acid residues 3270-3305; 36 residues; hereafter called BRCA2 Exon27 ) and RAD51. We found that BRCA2 Exon27 specifically recognizes and interacts with RAD51 oligomers and RAD51 nucleoprotein filaments. BRCA2 Exon27 protects RAD51 nucleoprotein filaments formed on ssDNA from disruption by the BRC repeats, and this protective effect is lost upon Ser3291 phosphorylation. Together, these observations suggest that BRCA2 Exon27 modulates BRC repeat function to maintain active nucleoprotein filaments during recombination-mediated DNA repair. Phosphorylation of BRCA2 Exon27 at the G 2 -M transition might terminate recombination by altering the balance in favor of the BRC repeat-dependent disassembly of RAD51 nucleoprotein filaments. into the molecular mechanism whereby BRCA2 regulates the recombination-mediated repair of DNA double-strand breaks by RAD51.
RESULTS

BRCA2 Exon27 binds oligomeric RAD51
The function of the human BRCA2 Exon27 sequence was investigated using as a control the well-characterized ability of BRC4 to disrupt RAD51 oligomers and RAD51 nucleoprotein filaments 16, 26 . RAD51 interactions were initially confirmed through streptavidin pull-down experiments using human RAD51 with biotinylated BRCA2 Exon27 , BRCA2 Exon27-Ph (a BRCA2 Exon27 sequence phosphorylated at residue Ser3291) and BRC4 peptides. Whereas BRCA2 Exon27 and BRC4 were able to bind RAD51, no interaction was detected between BRCA2 Exon27-Ph and RAD51 (Fig. 2a) . No interaction was observed with the Escherichia coli RAD51 ortholog RecA, confirming the specificity of BRCA2 Exon27 binding (data not shown). These results recapitulate previous findings 28 and confirm that the BRCA2 sequences chosen for this study are suitable for investigation of their complexes with RAD51. BRC repeats are able to interfere with the oligomeric state of RAD51 by mimicking RAD51's self-association mechanism 16, 26 . The lack of sequence similarity between BRCA2 Exon27 and the BRC repeat sequences suggests that their specific recognition of RAD51 is achieved through very different mechanisms. We tested the effect of BRCA2 Exon27 on the oligomeric state of RAD51 by nondenaturing gel electrophoresis. In isolation, recombinant RAD51 migrates as a single band corresponding to oligomeric species of net negative charge (Fig. 2b) . Preincubation of RAD51 with an equimolar amount of BRC4 caused a shift to a new species with reduced electrophoretic mobility, consistent with formation of a 1:1 BRC4-RAD51 complex (Fig. 2b) . The diminished mobility of the complex relative to free RAD51 is explained by the net positive charge of the BRC4 peptide. In contrast, BRCA2 Exon27 had no effect on the mobility of RAD51 (Fig. 2c) , suggesting that BRCA2 Exon27 binding does not alter the oligomeric state of RAD51. A fluorescently labeled version of the BRCA2 Exon27 sequence (Fl-BRCA2 Exon27 ) was used for direct visualization of BRCA2 Exon27 binding to RAD51. Isolated Fl-BRCA2 Exon27 did not move during gel electrophoresis (Fig. 2d) . However, the addition of RAD51 increased the electrophoretic mobility of Fl-BRCA2 Exon27 , causing it to migrate to the position of the RAD51 oligomer (Fig. 2d) . This indicates complex formation between BRCA2 Exon27 and RAD51.
To confirm these findings, BRCA2-RAD51 complexes were visualized through chemical cross-linking using bis(sulfosuccinimidyl) suberate (BS 3 ; Fig. 3a) . RAD51 cross-linking produced molecular species corresponding to a series of multimers ( Fig. 3b) , in agreement with its native oligomeric state. When we preincubated RAD51 with BRC4, a single new species was observed, corresponding to a 1:1 BRC4-RAD51 complex (Fig. 3c ), in keeping with the known functionality of BRC repeats 16, 26 . In contrast, preincubation with Fl-BRCA2 Exon27 permitted the cross-linking of RAD51 oligomers. In addition, new species corresponding to the BRCA2 Exon27 peptide crosslinked to one or two RAD51 protomers were detected (Fig. 3d) . UV visualization of Fl-BRCA2 Exon27 confirmed its cross-linking to the full spectrum of RAD51 oligomeric species (Fig. 3e) . These observations suggest that BRCA2 Exon27 interacts with RAD51 through a previously uncharacterized mechanism, distinct from that of the BRC repeats.
Specific recognition of oligomeric RAD51 by BRCA2 Exon27
The evidence so far indicates that BRCA2 Exon27 is capable of interacting with RAD51 without interfering with its oligomeric state. We next set out to investigate whether BRCA2 Exon27 binding actually relies on the oligomeric form of RAD51 or whether BRCA2 Exon27 can bind a single RAD51 protomer. This is particularly relevant if we consider that cellular RAD51 is likely to exist as either oligomers or monomers bound to the BRC repeats of BRCA2 (ref. 13 RAD51 oligomerization depends upon the insertion of hydrophobic residues from the interdomain linker of one protomer into matching pockets on the ATPase domain of the adjacent protomer 19, 26 (Fig. 4a) . Substitutions that invert the chemical nature of interface residues, such as F86E, prevent RAD51 oligomerization and thus create a constitutively monomeric form of RAD51. Indeed, an F86E RAD51 mutant fused to green fluorescent protein does not oligomerize in vivo, but retains an ability to bind BRCA2 (refs. 13,26) .
To determine whether the binding surface of BRCA2 Exon27 is contained within a single RAD51 protomer or spans adjacent protomers, we tested the ability of BRCA2 Exon27 to interact with a RAD51 mutant bearing the F86E substitution. As expected, the F86E RAD51 protein was retained on streptavidin beads when preincubated with biotinylated BRC4 (Fig. 4b) . However, the F86E RAD51 protein did not bind BRCA2 Exon27 above the level of the control (Fig. 4b) . We confirmed these results using a glutathione S-transferase (GST)-F86E RAD51 fusion protein, as we found that the presence of the tag improved the reduced stability of the mutant monomeric RAD51. As expected, BRC4 was able to bind the GST-F86E RAD51 protein (Fig. 4c) . However, neither BRCA2 Exon27 nor BRCA2 Exon27-Ph interacted with the monomeric form of RAD51 (Fig. 4c) , although BRCA2 Exon27 bound a GST-wild-type RAD51 fusion protein (Fig. 4d) . This evidence indicates that BRCA2 Exon27 specifically recognizes the RAD51 oligomer and is incapable of associating with monomeric RAD51. RAD51 ATPase domain is sufficient for BRCA2 Exon27 binding RAD51 is a two-domain protein formed by a smaller, helical N-terminal domain linked to a larger, evolutionarily conserved C-terminal ATPase domain. The dependence of the specific recognition by BRCA2 Exon27 on the oligomeric state of RAD51 suggests that the interaction is mediated by the ATPase domain. We designed an N-terminally truncated version of RAD51 (RAD51 ) that lacks the N-terminal domain but retains the linker region and ATPase domain necessary for self-association. The RAD51 80-339 protein could be selectively precipitated by spermidine similarly to full-length RAD51 (data not shown), and its oligomeric status was confirmed by gel-filtration analysis (Fig. 4e) . The interaction of BRC4 with the RAD51 80-339 protein was not affected (Fig. 4f) ; this is to be expected, as the BRC4-binding site is located in the ATPase domain. We found that BRCA2 Exon27 retained its ability to interact with the RAD51 80-339 protein, and that the interaction was abrogated by the Ser3291-phosphorylated form of BRCA2 Exon27 (Fig. 4f) . Thus, the N-terminal domain of RAD51 is not required for the interaction with the exon 27 region of BRCA2. Together, the evidence demonstrates that the interaction with BRCA2 Exon27 is mediated by the oligomeric ATPase domains of RAD51.
BRCA2 Exon27 binds the RAD51 nucleoprotein filament
The effect of BRCA2 Exon27 on the RAD51 nucleoprotein filament was tested by electrophoretic mobility shift assay (EMSA; Fig. 5a ). Adding increasing amounts of BRCA2 Exon27 to a RAD51 filament formed on fX174 virion ssDNA caused a minor retardation in mobility of the RAD51-DNA complex, with an upward smearing of the band (Fig. 5b) . As observed for free RAD51, the effect of BRCA2 Exon27 on the mobility of the RAD51-DNA complex was only slight. Thus, BRCA2 Exon27 binding does not eliminate the filament structure, in contrast to the ability of BRC4 to depolymerize RAD51 filaments. As the large size of the fX174 virion ssDNA might have masked the mobility shift induced by BRCA2 Exon27 , we tested the effect of BRCA2 Exon27 upon RAD51 filaments formed on a shorter, linear poly(dT) ssDNA substrate. As observed for the fX174 virion ssDNA, BRCA2 Exon27 induced a slight retardation and upward smearing of the RAD51-poly(dT) complex (Fig. 5c) . In addition, we tested the effect of BRCA2 Exon27 on RAD51 bound to a 24-base-pair (bp) dsDNA substrate with a 24-base 3¢ ssDNA tail, which mimics the ds-ssDNA junction formed at damaged loci in vivo. To form a stable complex with DNA, we used a RAD51 protein bearing an I287T mutation, which is known to increase the affinity toward DNA of yeast Rad51 (ref. 32). BRCA2 Exon27 induced a clear retardation in the mobility of the RAD51-DNA complex (Fig. 5d) , thus demonstrating that BRCA2 Exon27 binds the nucleoprotein filament.
To further confirm the interaction of BRCA2 Exon27 with the RAD51 filament, we performed EMSAs using the fluorescein-labeled Fl-BRCA2 Exon27 (Fig. 5e) . Isolated Fl-BRCA2 Exon27 did not show an appreciable electrophoretic mobility. The addition of increasing amounts of RAD51 induced a mobility shift of Fl-BRCA2 Exon27 to the position of the RAD51 oligomer (Fig. 5e) . Likewise, the addition of preformed RAD51-poly(dT) filament to Fl-BRCA2 Exon27 induced a change in its mobility to the position of the RAD51-DNA complex (Fig. 5e) . No mobility shift was observed upon the addition of DNA alone. These findings confirm that BRCA2 Exon27 can associate with the RAD51 oligomer and the RAD51 nucleoprotein filament.
BRCA2 Exon27 protects RAD51 filaments from BRC4 disassembly
The fact that the exon 27 and BRC-repeat sequences of BRCA2 have different modes of interaction with RAD51 suggests that they might play complementary roles in regulating RAD51 activity during homologous recombination. We tested this hypothesis by incubating with BRCA2 Exon27 a RAD51 nucleoprotein filament formed on fX174 virion ssDNA, before the addition of BRC4 (Fig. 6a) . Notably, BRCA2 Exon27 exerted a moderate but clear effect in preventing the disruption of the RAD51 nucleoprotein filament by BRC4 (Fig. 6b) . Furthermore, the protection was lost when the nucleoprotein filament was incubated with BRCA2 Exon27-Ph (Fig. 6c) , suggesting that the observed effect is a consequence of the specific interaction between BRCA2 Exon27 and RAD51.
The protection afforded by BRCA2 Exon27 against BRC4-dependent dissolution of the RAD51-fX174 virion ssDNA filament was not complete and required an excess of BRCA2 Exon27 over BRC4. To minimize possible effects of the DNA substrate's secondary structure, we repeated the experiment using the poly(dT) template. Notably, we found that BRCA2 Exon27 completely protected the RAD51-poly(dT) filament from an equimolar amount of BRC4 (Fig. 6d) . Preincubation with BRCA2 Exon27-Ph provided no protection (Fig. 6e) , confirming that the observed effect depends on specific RAD51 recognition by BRCA2 Exon27 . Moreover, BRCA2 Exon27 exerted a protective effect on a nucleoprotein filament formed between the ds-ssDNA substrate and I287T RAD51 (Fig. 6f) , which was also lost upon Ser3291 phosphorylation (Fig. 6g) .
The protective function of BRCA2 Exon27 was further tested through visualization of the nucleoprotein filament between RAD51 and poly(dT) by EM (Fig. 7a) . The presence of BRCA2 Exon27 did not cause disruption of the nucleoprotein filament or macroscopic modification of its overall morphology (Fig. 7b) , suggesting that BRCA2 Exon27 does not alter its conformation. In contrast, the addition of BRC4 completely depolymerized the RAD51 nucleoprotein filaments (Fig. 7c) , as previously reported 16 . Upon preincubation with BRCA2 Exon27 , the disruptive effect of BRC4 was entirely prevented and the RAD51 nucleoprotein filaments preserved their native morphology (Fig. 7d) . Thus, we have demonstrated by EMSA and EM that BRCA2 Exon27 protects RAD51-poly(dT) ssDNA nucleoprotein filaments from the known disruptive effect of BRC repeats.
BRCA2 Exon27 protection is unique to RAD51-ssDNA filaments
We further dissected the specificity of the observed protective function of BRCA2 Exon27 : in the absence of DNA, BRCA2 Exon27 was unable to prevent the conversion of oligomeric RAD51 to the 1:1 RAD51-BRC4 complex form (Fig. 8a) . The protective effect conferred upon RAD51-poly(dT) filaments was maintained when ATP was replaced by the nonhydrolyzable nucleotide analog AMP-PNP, indicating that the BRCA2 Exon27 function is independent of ATP hydrolysis ( Fig. 8b ; compare with Fig. 6d ). However, we observed no protective effect of BRCA2 Exon27 when preincubated with RAD51 filaments containing either circular fX174 dsDNA or a linear, 1.2-kbp dsDNA (Fig. 8c,d ). As RAD51 ATPase activity is known to be differentially activated by ssDNA and dsDNA 33 , we tested the effect of BRCA2 Exon27 on RAD51 filaments formed on the linear 1.2-kbp dsDNA substrate in the presence of AMP-PNP (Fig. 8e) . Although higher concentrations of BRC4 were required to dissolve the RAD51-dsDNA filaments in the presence of AMP-PNP, preincubation with BRCA2 Exon27 only mildly potentiated this effect (Fig. 8e) . Our data thus show that, although BRCA2 Exon27 can interact with RAD51 in the absence of DNA, its protective effect against disruption by BRC repeats is specific to nucleoprotein filaments formed on ssDNA. The specific action of BRCA2 Exon27 toward RAD51 complexes containing ssDNA is particularly noteworthy, as the RAD51 filaments formed on ssDNA are thought to be the active filament form in recombinationmediated repair. characterized, much less is known about the mode of interaction of RAD51 with the C-terminal binding site coded within exon 27 of BRCA2, BRCA2 Exon27 . Here we have provided a first account of the mechanism by which BRCA2 Exon27 interacts with RAD51. We find that a 36-amino-acid-residue sequence within a highly conserved region encoded by exon 27 specifically recognizes and interacts with RAD51 oligomers and RAD51 nucleoprotein filaments: unlike the BRC repeats, BRCA2 Exon27 does not bind a monomeric RAD51 mutant and is unable to interfere with the oligomeric state of RAD51. Furthermore, we show that the ATPase domain of RAD51 is sufficient for the interaction with BRCA2 Exon27 , whereas the N-terminal domain is not required for binding. These observations can be integrated in a model in which BRCA2 Exon27 occupies the groove formed by adjacent protomers of oligomeric RAD51 assemblies, making specific contacts with the ATPase domains of neighboring subunits. The observation that mutations of Ser3291 to alanine and glutamic acid abrogate RAD51 binding implicates the hydroxyl moiety of the serine in a crucial hydrogen-bonding interaction, possibly required to maintain the conformation of the exon 27 region necessary for RAD51 binding. The conservative mode of RAD51 binding by BRCA2 Exon27 contrasts with the ability of BRC repeats to disrupt RAD51 oligomers and nucleoprotein filaments through the formation of 1:1 BRC-RAD51 complexes 8, 16, 26 . Thus, BRCA2 can bind RAD51 in multiple ways: through the disruptive action of BRC repeats, with a potential RAD51-remodeling function; through a nondisruptive association of the BRC repeats with RAD51 filaments; and through the conservative interaction of the exon 27 region, which stabilizes the RAD51-ssDNA nucleoprotein filament. We have further defined a functional interplay between RAD51-binding modes by demonstrating that BRCA2 Exon27 can protect RAD51 nucleoprotein filaments from disassembly by BRC repeats. The effect is specific to ssDNA, as free RAD51 and RAD51 filaments formed on dsDNA are not protected upon binding to BRCA2 Exon27 . These observations suggest that once the BRC repeats have remodeled free oligomeric RAD51 into RAD51 nucleoprotein filaments, BRCA2 Exon27 might stabilize and protect the filaments from subsequent BRC repeat-dependent disruption. Notably, although BRC repeats have been identified in BRCA2 molecules from a wide range of eukaryotes, the C-terminal RAD51-binding motif is specific to vertebrate BRCA2 sequences. It is possible that the BRCA2 Exon27 sequence of vertebrate proteins might have evolved to protect RAD51 nucleoprotein filaments from the disruptive effects of their BRC repeats. In this respect, it will be interesting to compare the disruptive potency toward RAD51 nucleoprotein filaments of vertebrate BRC repeats with that of the single BRC repeat found in primitive BRCA2 proteins lacking the BRCA2 Exon27 RAD51-binding motif.
Homologous recombination is active during the S and G 2 phases of the cell cycle and is terminated at the G 2 -M transition to prepare for cellular entry into mitosis. As phosphorylation of Ser3291 at the G 2 -M transition abrogates the ability of BRCA2 Exon27 to bind RAD51, it has been proposed that this phosphorylation event is in part responsible for terminating recombination before mitosis 28 . Here, we present a mechanistic explanation for this observation. It has previously been reported that BRC repeats may interact with RAD51 in ways that can interfere or be compatible with its oligomeric state and that both binding modes are likely to be relevant to recombination-mediated repair. In the context of the surrounding sequence encoded by exon 11, BRCA2 BRC1-8 can stimulate strand exchange through a direct association with the RAD51 filament 11 . However, when present in excess, individual BRC repeats 16, 27 and the BRCA2 BRC1-8 region (O.R.D. and L.P., unpublished data) can disrupt RAD51 filaments. Remodeling cellular RAD51 into nucleoprotein filaments is probably an important function of the BRC repeats, but it also raises the possibility that the BRC repeats may inadvertently disrupt RAD51 filaments that are engaged in repair. This highlights a requirement for a cellular mechanism that permits remodeling of free oligomeric RAD51 at the onset of repair but protects established RAD51 filaments during active repair. The work presented here suggests that the exon 27 region of BRCA2 may fulfill such protective function: we find that BRCA2 Exon27 specifically stabilizes RAD51-ssDNA filaments against interference from BRC repeats. At the G 2 -M transition, CDK phosphorylation removes the ability of BRCA2 Exon27 to preserve the integrity of RAD51-ssDNA filaments from BRC repeat-dependent depolymerization. We propose that this shift in balance between the disruptive and protective functions of BRCA2 induces filament disassembly upon cellular entry into mitosis, thus terminating recombination. 
METHODS
Protein expression and purification. Full-length human RAD51, I287 T RAD51 and RAD51 80-339 were expressed in BL21(DE3) cells as untagged polypeptides and purified as described 34 . GST-RAD51 and GST-F86E RAD51 were expressed in pGAT3 vectors 35 in BL21(DE3) cells and purified using nickel-nitrilotriacetic acid resin (Qiagen). The GST tag was removed from GST-F86E RAD51 by incubation with tobacco etch virus protease (Invitrogen); F86E RAD51 was then purified by incubation with nickel-nitrilotriacetic acid resin (Qiagen). Mutations were introduced to the RAD51 sequence using a sitedirected mutagenesis kit (Stratagene).
Peptide synthesis. Peptides containing N-terminal biotin or fluorescein labels were synthesized by solid-phase peptide synthesis (Alta Bioscience, University of Birmingham). BRCA2 Exon27 corresponds to ALDFLSRLPLPPPVSPICTFV SPAAQKAFQPPRSCG (human BRCA2 residues 3270-3305; BRCA2 Exon27-Ph contains a phosphorylated serine residue at position 3291); BRC4 corresponds to EKIKEPTLLGFHTASGKKVKIAKESLDKVKNLFDE (human BRCA2 residues 1514-1548). During early experimental work, the two cysteine residues of BRCA2 Exon27 were found to be highly susceptible to oxidation, which could be remedied by the presence of 20 mM DTT.
